摘要
【摘要】 目的 分析左氧氟沙星联合抗结核药物治疗肺结核合并肺部感染患者的临床效果。方法 64例肺结核合并肺部感染患者， 采用抽签法分为对照组与实验组， 每组 32例。对照组患者接受常规抗结核药物治疗， 实验组患者接受左氧氟沙星联合抗结核药物治疗。比较两组患者并发症发生情况、治疗效果。结果 实验组患者并发症发生率 9.38%低于对照组的 31.25%， 总有效率 90.63%高于对照组的 75.00%， 差异有统计学意义（ P<0.05）。结论 采用左氧氟沙星联合抗结核药物治疗肺结核合并肺部感染患者效果显著， 可有效预防并发症， 安全性高， 可在临床推广及使用。
【关键词】 左氧氟沙星 ;抗结核药物 ;肺结核 ;肺部感染
[Abstract] Objective To analyze the clinical effect of levofloxacin combined with anti tuberculosis drugs in the treatment of pulmonary tuberculosis complicated with pulmonary infection. Methods 64 patients with pulmonary tuberculosis complicated with pulmonary infection were randomly divided into control group and experimental group, 32 cases in each group. The control group received conventional anti tuberculosis drug treatment, and the experimental group received levofloxacin combined with anti tuberculosis drugs. The complications and treatment effect of the two groups were compared. Results the incidence of complications in the experimental group was 9.38%, which was lower than 31.25% of the control group, and the total effective rate was 90.63% higher than 75.00% of the control group, the difference was statistically significant (P < 0.05). Conclusion levofloxacin combined with antituberculosis drugs in the treatment of pulmonary tuberculosis complicated with pulmonary infection has significant effect, can effectively prevent complications, high safety, can be popularized and used in clinic.
出版日期
2020年09月12日（中国期刊网平台首次上网日期，不代表论文的发表时间）
